Company
Headquarters: Hangzhou, China
Employees: 8,326
CN¥52.93 Billion
CNY as of July 1, 2023
US$7.30 Billion
Company | Market Cap (USD) |
---|---|
![]() |
$199.03 B |
![]() |
$175.38 B |
![]() |
$62.71 B |
![]() |
$49.13 B |
![]() |
$43.73 B |
Company | Market Cap (USD) |
---|---|
![]() |
$428.70 B |
![]() |
$417.05 B |
![]() |
$412.24 B |
![]() |
$329.83 B |
![]() |
$275.82 B |
Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in China and internationally. It operates through Clinical Trial Solutions; and Clinical-Related and Laboratory Services. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting; clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system; and biometrics services covering data management, biostatistics, and statistical programming. It also provides integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital; medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value added services; and post-marketing study, real world evidence, and vaccine clinical trial services. The company was incorporated in 2004 and is headquartered in Hangzhou, China.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!
Hangzhou Tigermed Consulting Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300347 wb_incandescent
Stock: FSX: 5HZ1 wb_incandescent
Stock: HKEX: 3347 wb_incandescent